Skip to main content

Jesus Castro Marrero

Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain.

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Jesus Castro Marrero

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain.

Jesus Castro earned his Postdoctoral Researcher Fellowship degree in Biochemistry and Molecular Biology program at the Valladolid University School of Medicine, Spain in 1999. Dr. Castro is currently a Senior Postdoctoral Research at the Vall d’Hebron Hospital Research Institute, University of Barcelona School of Medicine, Barcelona, Spain since 2002. In the past 20 years have been devoted to basic research of respiratory medicine, autoimmune and rheumatic conditions with over 50 high-impact factor publications and book chapters. He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain. Dr. Castro is a member of the E.U. CFS/ME Research Collaborative Consortium Initiative (European Myalgic Encephalomyelitis NEtwork-EUROMENE). His current research is focused on the bioenergetic metabolism, mitochondrial dysfunction, and neuroimmune pathways linked to the immune response in CFS/ME, as well as finding useful biomarkers to aid in the diagnosis, treatment, and management of CFS/ME through clinical trials in order to improve prognosis and quality of life of CFS/ME patients.

Projects

Fatiga Crónica (GRE)

IP: -
Collaborators: Tomás Fernández de Sevilla Ribosa, Jesus Castro Marrero, Eva Ruiz Ruiz
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 340
Duration: 01/01/2014 - 31/12/2016

Ensayo clínico aleatorizado y controlado para evaluar la eficacia de la azatioprina vs. micofenolato sódico para el tratamiento de la fase de inducción y mantenimiento de la remisión de los brotes extra renales del lupus eritematoso sistémico (EUDRA 2008

IP: Josefina Cortes Hernandez
Collaborators: José Ordi Ros, Miguel Vilardell Tarres, Jesus Castro Marrero, Pilar Suñe Martin
Funding agency: Ministerio Sanidad
Funding: 213508.13
Reference: TRA-188
Duration: 01/01/2010 - 31/12/2013

Estudio para evaluar la eficacia y seguridad de la lenalidomida en el tratamiento del lupus eritematoso cutáneo

IP: José Ordi Ros
Collaborators: J. Bruno Montoro Ronsano, Josefina Cortes Hernandez, Jesus Castro Marrero
Funding agency: Ministerio Sanidad
Funding: 204000
Reference: TRA-194
Duration: 01/01/2010 - 31/12/2010

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Related news

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.